Success Metrics

Clinical Success Rate
83.0%

Based on 899 completed trials

Completion Rate
83%(899/1083)
Active Trials
269(17%)
Results Posted
43%(383 trials)
Terminated
184(11%)

Phase Distribution

Ph phase_1
391
24%
Ph not_applicable
112
7%
Ph phase_4
4
0%
Ph early_phase_1
25
2%
Ph phase_3
344
21%
Ph phase_2
706
44%

Phase Distribution

416

Early Stage

706

Mid Stage

348

Late Stage

Phase Distribution1582 total trials
Early Phase 1First-in-human
25(1.6%)
Phase 1Safety & dosage
391(24.7%)
Phase 2Efficacy & side effects
706(44.6%)
Phase 3Large-scale testing
344(21.7%)
Phase 4Post-market surveillance
4(0.3%)
N/ANon-phased studies
112(7.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.9%

899 of 1169 finished

Non-Completion Rate

23.1%

270 ended early

Currently Active

269

trials recruiting

Total Trials

1,620

all time

Status Distribution
Active(288)
Completed(899)
Terminated(270)
Other(163)

Detailed Status

Completed899
Terminated184
unknown158
Active, not recruiting143
Recruiting126
Withdrawn86

Development Timeline

Analytics

Development Status

Total Trials
1620
Active
269
Success Rate
83.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 125 (1.6%)
Phase 1391 (24.7%)
Phase 2706 (44.6%)
Phase 3344 (21.7%)
Phase 44 (0.3%)
N/A112 (7.1%)

Trials by Status

suspended50%
terminated18411%
active_not_recruiting1439%
withdrawn865%
enrolling_by_invitation10%
not_yet_recruiting181%
recruiting1268%
unknown15810%
completed89955%

Recent Activity

Clinical Trials (1,620)

Showing 20 of 1,620 trialsScroll for more
NCT01857934Phase 2

Therapy for Children With Advanced Stage Neuroblastoma

Completed
NCT02615275Not Applicable

Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy

Active Not Recruiting
NCT02626312Phase 1

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

Active Not Recruiting
NCT06702033Phase 2

The Minimalist Trial-2

Recruiting
NCT02468024Phase 3

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Recruiting
NCT07237269Phase 2

Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer

Recruiting
NCT03398161Phase 2

Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides

Recruiting
NCT06760481Phase 1

Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER)

Active Not Recruiting
NCT03680586Early Phase 1

Ultra Low-Dose Radiation Therapy in Treating Patients With Stage I-IV Stomach MALT Lymphoma

Active Not Recruiting
NCT04580771Phase 2

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

Active Not Recruiting
NCT03161522Phase 2

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Recruiting
NCT06770582Phase 2

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Recruiting
NCT04481204Phase 2

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Active Not Recruiting
NCT04402788Phase 2

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Recruiting
NCT05336383Phase 2

Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma

Recruiting
NCT06124157Phase 2

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Recruiting
NCT06172296Phase 3

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Recruiting
NCT02106988Phase 2

Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma

Active Not Recruiting
NCT05099003Phase 1

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Recruiting
NCT03907488Phase 3

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

Active Not Recruiting

Drug Details

Intervention Type
RADIATION
Total Trials
1,620